Related Experiment Video
Updated: Sep 6, 2025

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
Trends in the Prevalence of Chronic Medication Use Among Children in Israel Between 2010 and 2019: Protocol for a
Yair Sadaka1,2, Dana Horwitz1, Leor Wolff3
1Neuro-Developmental Research Centre, Beer Sheva Mental Health Centre, Ministry of Health, Beer Sheva, Israel.
Insights
This study analyzes trends in psychobehavioral and non-psychobehavioral medication use in children, identifying risk factors for chronic treatment. Findings aim to improve pediatric prescription policies and chronic care management.
Area of Science:
- Pediatric pharmacology
- Health services research
- Biostatistics
Background:
- Global increase in psychostimulant prescriptions for children.
- Need to understand chronic medication use trends across pediatric age groups and sociodemographic factors.
- Importance of differentiating therapy areas for cost and service evaluation.
Purpose of the Study:
- Analyze trends in psychobehavioral vs. non-psychobehavioral medication prescriptions in children.
- Identify risk factors and predictors for chronic medication use in pediatric populations.
Main Methods:
- Retrospective study using Clalit Health Services data (2010-2019, ~1.5 million children aged 0-18).
- Anatomical Therapeutic Chemical (ATC) codes for medication identification.
- Time-trend analysis comparing psychobehavioral and non-psychobehavioral medication prescription trends.
- Logistic regression and machine learning to identify risk variables and predict chronic treatment.
Main Results:
- Data analysis is ongoing; results submission expected in 2022.
- Study aims to elucidate trends in pediatric psychobehavioral and non-psychobehavioral medication use.
- Expected to identify key risk factors and predictors for chronic medication use in children.
Conclusions:
- Analysis of patient population response over time can inform prescription and follow-up policies.
- Potential to improve management of chronic treatments for children.
- Aims to enhance decision-making for healthcare providers and policymakers regarding pediatric medication.
Background:
Prescription of psychostimulants has significantly increased in most countries worldwide for both preschool and school-aged children. Understanding the trends of chronic medication use among children in different age groups and from different sociodemographic backgrounds is essential. It is essential to distinguish between selected therapy areas to help decision-makers evaluate not only the relevant expected medication costs but also the specific services related to these areas.
Objective:
This study will analyze differences in trends regarding medications considered psychobehavioral treatments and medications considered nonpsychobehavioral treatments and will identify risk factors and predictors for chronic medication use among children.
Methods:
This is a retrospective study. Data will be extracted from the Clalit Health Services data warehouse. For each year between 2010 and 2019, there are approximately 1,500,000 children aged 0-18 years. All medication classes will be identified using the Anatomical Therapeutic Chemical code. A time-trend analysis will be performed to investigate if there is a significant difference between the trends of children's psychobehavioral and nonpsychobehavioral medication prescriptions. A logistic regression combined with machine learning models will be developed to identify variables that may increase the risk for specific chronic medication types and identify children likely to get such treatment.
Results:
The project was funded in 2019. Data analysis is currently underway, and the results are expected to be submitted for publication in 2022. Understanding trends regarding medications considered psychobehavioral treatments and medications considered nonpsychobehavioral treatments will support the identification of risk factors and predictors for chronic medication use among children.
Conclusions:
Analyzing the response of the patient (and their parents or caregivers) population over time will hopefully help improve policies for prescriptions and follow-up of chronic treatments in children.
International Registered Report Identifier (Irrid):
DERR1-10.2196/36756.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
07:51Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Related Concept Videos
Factors Affecting Drug Response: Overview
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Longitudinal Studies
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data